...
search icon
azn-img

AstraZeneca PLC Share Price

AZN
NYQ
$205.79
-$0.82
(-0.4%)
1D
Industry: Pharmaceuticals Sector: Health Care

AstraZeneca PLC Analyst Forecast

AstraZeneca PLC Share Price Chart

AstraZeneca PLC Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$320.30B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
31.5435
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.43M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
1.67%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.19
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$120.37 L
$210.5 H
$205.79

About AstraZeneca PLC, Common Stock

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Crestor, Seloken, Lokelma, Roxadustat, Andexxa, Wainua, Symbicort, Fasenra, Pulmicort, Breztri/Trixeo, Saphnelo, Tezspire, Airsupra, Ultomiris, Soliris, Strensiq, Koselugo, Kanuma, Atacand, Plendil, Modip, Splendil, Munobal, Flodil, Komboglyze, Qtern, Byetta, XIGDUO, Accolate, Accoleit, Vanticon, Beyfortus, Synagis, FluMist, tixagevimab and cilgavimab, and sipavibart. It also provides Bricanyl Respules, Eklira Genuair/Tudorza/Bretaris, Bricanyl Turbuhaler, Rhinocort, Bevespi Aerosphere, Daliresp/Daxas, Oxis Turbuhaler, Breztri Aerosphere, Duaklir Genuair, Kavigale, Evusheld, Fluenz/FluMist, and Voydeya. The company offers its products for ocology, cardiovascular, renal and metabolism, respiratory & immunology, vaccines and immune, and therapies rare diseases. It serves primary and specialty care physicians through distributors and local representative offices in the United Kingdom, the United States, Europe, and Asia. It has a strategic agreement with Tempus to develop the largest multimodal foundation model in oncology. The company has a collaboration agreement with IonQ, Inc. for the development of quantum-accelerated computational chemistry workflow for healthcare, life sciences, and chemistry; a strategic research collaboration with CSPC Pharmaceutical Group Limited to advance the discovery and development of novel oral candidates, with the potential to treat diseases across multiple indications and multiple next-generation therapies for obesity and type 2 diabetes; and collaboration Revna Biosciences for lung cancer treatment. AstraZeneca PLC was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the Uni more

Industry: PharmaceuticalsSector: Health Care

AstraZeneca PLC Stock Returns

Time FrameAZNSectorS&P500
1-Week Return-0.99%0.13%0.17%
1-Month Return9.63%-0.15%-0.77%
3-Month Return10.79%-0.57%1.86%
6-Month Return29.68%15.91%7.03%
1-Year Return37.01%6.03%15.7%
3-Year Return54.65%23.22%72.98%
5-Year Return111.21%38.98%79.85%
10-Year Return248.53%134.16%252.58%

AstraZeneca PLC Financials

Dec '21Dec '22Dec '23Dec '24Dec '255YR TREND
Total Revenue37.42B44.35B45.81B54.07B58.74B[{"date":"2021-12-31","value":63.7,"profit":true},{"date":"2022-12-31","value":75.51,"profit":true},{"date":"2023-12-31","value":77.99,"profit":true},{"date":"2024-12-31","value":92.06,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Cost of Revenue12.44B12.39B8.27B10.21B10.63B[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":99.63,"profit":true},{"date":"2023-12-31","value":66.48,"profit":true},{"date":"2024-12-31","value":82.07,"profit":true},{"date":"2025-12-31","value":85.49,"profit":true}]
Gross Profit24.98B31.96B37.54B43.87B48.11B[{"date":"2021-12-31","value":51.93,"profit":true},{"date":"2022-12-31","value":66.44,"profit":true},{"date":"2023-12-31","value":78.04,"profit":true},{"date":"2024-12-31","value":91.19,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Gross Margin66.76%72.06%81.95%81.12%81.90%[{"date":"2021-12-31","value":81.46,"profit":true},{"date":"2022-12-31","value":87.93,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":98.99,"profit":true},{"date":"2025-12-31","value":99.93,"profit":true}]
Operating Expenses23.92B28.20B29.35B33.86B34.36B[{"date":"2021-12-31","value":69.62,"profit":true},{"date":"2022-12-31","value":82.07,"profit":true},{"date":"2023-12-31","value":85.41,"profit":true},{"date":"2024-12-31","value":98.54,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Operating Income1.06B3.76B8.19B10.00B13.74B[{"date":"2021-12-31","value":7.68,"profit":true},{"date":"2022-12-31","value":27.34,"profit":true},{"date":"2023-12-31","value":59.62,"profit":true},{"date":"2024-12-31","value":72.79,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense(2.55B)(2.50B)(2.58B)(2.65B)(2.67B)[{"date":"2021-12-31","value":-255400000000,"profit":false},{"date":"2022-12-31","value":-250500000000,"profit":false},{"date":"2023-12-31","value":-258200000000,"profit":false},{"date":"2024-12-31","value":-264900000000,"profit":false},{"date":"2025-12-31","value":-267500000000,"profit":false}]
Pre-Tax Income(265.00M)2.50B6.90B8.69B12.40B[{"date":"2021-12-31","value":-2.14,"profit":false},{"date":"2022-12-31","value":20.17,"profit":true},{"date":"2023-12-31","value":55.63,"profit":true},{"date":"2024-12-31","value":70.08,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Income Taxes(380.00M)(792.00M)938.00M1.65B2.17B[{"date":"2021-12-31","value":-17.52,"profit":false},{"date":"2022-12-31","value":-36.51,"profit":false},{"date":"2023-12-31","value":43.25,"profit":true},{"date":"2024-12-31","value":76.07,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Income After Taxes115.00M3.29B5.96B7.04B10.23B[{"date":"2021-12-31","value":1.12,"profit":true},{"date":"2022-12-31","value":32.18,"profit":true},{"date":"2023-12-31","value":58.25,"profit":true},{"date":"2024-12-31","value":68.81,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Income From Continuous Operations115.00M3.29B5.96B7.04B10.23B[{"date":"2021-12-31","value":1.12,"profit":true},{"date":"2022-12-31","value":32.18,"profit":true},{"date":"2023-12-31","value":58.25,"profit":true},{"date":"2024-12-31","value":68.81,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Income From Discontinued Operations-----[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Net Income112.00M3.29B5.96B7.04B10.26B[{"date":"2021-12-31","value":1.09,"profit":true},{"date":"2022-12-31","value":32.06,"profit":true},{"date":"2023-12-31","value":58.07,"profit":true},{"date":"2024-12-31","value":68.6,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
EPS (Diluted)0.272.113.824.59-[{"date":"2021-12-31","value":5.93,"profit":true},{"date":"2022-12-31","value":45.91,"profit":true},{"date":"2023-12-31","value":83.12,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]

AstraZeneca PLC Ratios

AstraZeneca PLC Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

AZN
Cash Ratio 0.19
Current Ratio 0.94
Quick Ratio 0.72

AstraZeneca PLC Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

AZN
ROA (LTM) 7.88%
ROE (LTM) 22.84%

AstraZeneca PLC Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

AZN
Debt Ratio Lower is generally better. Negative is bad. 0.57
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.43

AstraZeneca PLC Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

AZN
Trailing PE 31.54
Forward PE 16.08
P/S (TTM) 5.45
P/B 5.71
Price/FCF 233
EV/R 5.06
EV/Ebitda 16.98
PEG 1.08

FAQs

What is AstraZeneca PLC share price today?

AstraZeneca PLC (AZN) share price today is $205.79

Can Indians buy AstraZeneca PLC shares?

Yes, Indians can buy shares of AstraZeneca PLC (AZN) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in AZN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of AstraZeneca PLC be purchased?

Yes, you can purchase fractional shares of AstraZeneca PLC (AZN) via the Vested app. You can start investing in AstraZeneca PLC (AZN) with a minimum investment of $1.

How to invest in AstraZeneca PLC shares from India?

You can invest in shares of AstraZeneca PLC (AZN) via Vested in three simple steps:

  • Click on Sign Up or Invest in AZN stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in AstraZeneca PLC shares
What is AstraZeneca PLC 52-week high and low stock price?

The 52-week high price of AstraZeneca PLC (AZN) is $210.5. The 52-week low price of AstraZeneca PLC (AZN) is $120.37.

What is AstraZeneca PLC price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of AstraZeneca PLC (AZN) is 31.5435

What is AstraZeneca PLC price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of AstraZeneca PLC (AZN) is 5.71

What is AstraZeneca PLC dividend yield?

The dividend yield of AstraZeneca PLC (AZN) is 1.67%

What is the Market Cap of AstraZeneca PLC?

The market capitalization of AstraZeneca PLC (AZN) is $320.30B

What is AstraZeneca PLC's stock symbol?

The stock symbol (or ticker) of AstraZeneca PLC is AZN

How Can Investors Use AstraZeneca PLC Share Price Data for Long-Term Investment Decisions?

Consider the share price of AstraZeneca PLC as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether AstraZeneca PLC has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from AstraZeneca PLC shares for Indian investors?

When investing in AstraZeneca PLC shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the AstraZeneca PLC stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare AstraZeneca PLC share price with other stocks in the same sector?

Rather than merely checking the share price of AstraZeneca PLC and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that AstraZeneca PLC stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top